Скачать или смотреть Unpacking FDA's Final Clinical Decision Support Guidance - Diagnosing Health Care Episode #57

The U.S. Food and Drug Administration (FDA) recently issued a final guidance document, clarifying how the agency intends to regulate clinical decision support (CDS) software. How has this document caused confusion for industry? How can companies respond?

On this episode, Epstein Becker Green attorneys Brad Thompson and Jessika Tuazon analyze the FDA's latest CDS guidance and discuss the challenges industry faces as it attempts to make sense of, and comply with, that guidance.

Visit our site for related resources and email contact information: https://www.ebglaw.com/dhc57.

The Diagnosing Health Care podcast examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.

Listen to the series and subscribe for email notifications: http://diagnosinghealthcare.com.

These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.